Menu

IoT FEATURE NEWS

Intel Partners with the Michael J. Fox Foundation to Fight Disease

By

At a Sparks Summit conference, Ido Karvanay, Big Data Architect, Intel, spoke to the attendees about the work that Intel and the Michael J. Fox Foundation (MJFF) have done to continue the research of Parkinson’s disease through develop data analytics wearables.

 

Parkinson’s disease is a degenerative disorder of the central nervous system mainly affecting motor functions. Currently, there are 1 million Parkinson’s Disease patients and one out of 100 are over the age of sixty. There isn’t a known cure for Parkinson’s disease.
 

Intel and the Michael J. Fox Foundation hope to change this. “Nearly 200 years after Parkinson’s disease was first described by Dr. James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then,” said Todd Sherer, PhD, CEO, The Michael J. Fox Foundation. “Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”
 

These analytics-enabled wearables are tech-enabled solutions like watches and smartphone apps that gather relevant data about Parkinson’s disease from the patients, analyze that data to identify patterns and make generalizations, use insights gained to accelerate the development of therapeutic breakthroughs, and potentially help find a cure for the disease.
 

“The variability in Parkinson’s symptoms creates unique challenges in monitoring progression of the disease,” said Diane Bryant, SVP and GM, Data Center Group, Intel. “Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.”


One of the top challenges that Parkinson’s disease specialists encounter is acquiring a normal day’s results from their patients. “One of the main challenges is subjective measurement,” Karvanay said. Doctors don’t get a clear idea of a patient’s symptoms because they only see them once a month or so, causing the patients’ symptoms to spike due to nervousness or apprehension while visiting their physician.
 

Intel and the Michael J. Fox Foundation will continue their collaboration together as more information, results, and data is collected.




Edited by Ken Briodagh
Get stories like this delivered straight to your inbox. [Free eNews Subscription]
SHARE THIS ARTICLE
Related Articles

I've Asked the Security Experts, But It's Time You Have Your Say

By: Carl Ford    6/27/2025

Security experts are quick to say they know what's happening, but here's your opportunity to weigh in on the state of cybersecurity in IoT.

Read More

Mary Meeker Returns with AI and Breezes Past AIoT

By: Carl Ford    6/26/2025

We are entering an era where intelligence is not just embedded in digital applications, but also in vehicles, machines, and defense systems

Read More

Nothreat Fights AI Fire with AI in Firewalls

By: Carl Ford    6/26/2025

According to Nothreat, the only way to fight AI cyber threats in IoT with AI is to go beyond detection and into active containment, deception, and aut…

Read More

How Kapitus is Reshaping SMB Funding

By: Carl Ford    6/16/2025

Kapitus is a financial institution that provides various financing solutions to SMBs, operating as both a direct lender and a financing marketplace.

Read More

Slicing Up the Network with 5G SA: An Interview with Telit Cinterion's Stan Gray

By: Carl Ford    6/10/2025

Carl Ford speaks with Stan Gray about 5G SA, network slicing, and trends, challenges, and opportunities related to both.

Read More